Lipocine Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.2M | $6.2M | $4.8M | $3.1M | $3.0M | $19.2M | $9.7M | $8.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $16.9M | $22.3M | $22.9M | $34.1M | $46.4M | $25.3M | $19.6M | $20.8M |
| Property, Plant & Equipment | $104.3K | $165.1K | $116.1K | $131.6K | $7.2K | — | $3.6K | $19.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $17.0M | $22.5M | $23.0M | $37.5M | $52.5M | $25.4M | $19.7M | $20.9M |
| Liabilities | ||||||||
| Accounts Payable | $971.8K | $271.7K | $1.4M | $600.4K | $1.3M | $1.6M | $1.2M | $671.3K |
| Total Current Liabilities | $2.5M | $1.5M | $2.6M | $1.7M | $5.6M | $6.6M | $5.0M | $4.5M |
| Long-Term Debt | — | — | — | — | $1.7M | $2.3M | $3.8M | $6.9M |
| Total Liabilities | $2.5M | $1.5M | $2.6M | $1.9M | $6.9M | $10.0M | $13.4M | $11.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-209.4M | $-199.8M | $-199.8M | $-183.4M | $-172.7M | $-172.0M | $-151.1M | $-138.1M |
| Total Stockholders' Equity | $14.5M | $21.0M | $20.4M | $35.6M | $45.6M | $15.3M | $6.3M | $9.4M |